Industry Pharmaceutical Number of employees 2,500 Motto Contrast for Life | Website www.guerbet.com Revenue 489 million EUR (2015) Founded 1926 | |
![]() | ||
Stock price GBT (EPA) € 84.30 +1.13 (+1.36%)10 Mar, 5:35 PM GMT+1 - Disclaimer Subsidiaries Guerbet Korea Ltd, Guerbet Nederland B.V |
Ecr 2016 guerbet is presenting its new global offers
Guerbet is a research-centered pharmaceutical company based in France that is one of the major players in the contrast agents business.
Contents
The company's main products are:
A new guerbet at rsna 2015
History
The company is named after the French chemist Marcel Guerbet (1861–1938), who produced Lipiodol in 1901 and his son André Guerbert, who founded the company in 1926. The X-ray contrast properties of Lipiodol were discovered in 1918.
On July 27, 2015, Guerbet announced that it has entered into a definitive agreement under which it will acquire Mallinckrodt’s contrast media and delivery systems business ("CMDS").
On November 27, 2015, Guerbet completed acquisition of Mallinckrodt’s Contrast Media and Delivery Systems business ("CMDS"), for $270M in cash, financed by BNP Paribas.
References
Guerbet Wikipedia(Text) CC BY-SA